UNITED THERAPEUTICS CORP (UTHR) Institutional Ownership

UTHR is currently held by 3 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.06B based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $1.06B in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's UTHR position is now estimated to be worth approximately $972.73M, representing an estimated loss of -8.20% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Sequoia Financial Advisors, Mairs & Power Growth Fund, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks disclosed ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward UNITED THERAPEUTICS CORP (UTHR).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20263$1,061,311,4541,789,793
Q4 20252$931,880,2431,912,530
Q3 20252$911,855,5312,175,176
Q2 20252$609,227,6892,120,159
Q1 20252$649,728,0412,107,659
Q4 20242$737,522,0462,090,245
Q3 20242$772,643,8112,156,115
Q2 20243$693,462,0082,176,933
Q1 20242$976,0152,153,811
Q4 20232$921,8262,172,236
Q3 20232$929,1182,252,371
Q2 20232$940,6632,189,288